Bcl-2 and p21 immunostaining of cervical tubo-endometrial metaplasia [3]

Histopathology

Volumn 40, Issue 1, 2002, Pages 107-108

  McCluggage, W G ^a   Maxwell, P ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN P21;

CELL STRUCTURE; CILIATED EPITHELIUM; ENDOMETRIUM; ENDOMETRIUM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; METAPLASIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SECRETORY CELL; UTERINE CERVIX DISEASE; UTERINE TUBE;

BIOLOGICAL MARKERS; CERVIX UTERI; ENDOMETRIOSIS; ENDOMETRIUM; FALLOPIAN TUBES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; METAPLASIA; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS P21(RAS); UTERINE CERVICAL DISEASES;

EID: 0036153582     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2002.1340d.x     Document Type: Letter

References (5)

1. Cell cycle-related proteins p21 and bcl-2: Markers of differentiation in the human fallopian tube
2. Immunohistochemical detection of p53 and bcl-2 proteins in neoplastic and non-neoplastic endocervical glandular lesions
3. Cone biopsy causes cervical endometriosis and tubo-endometrioid metaplasia
4. The prevalence of tubo-endometrial metaplasia and adenomatoid proliferation
5. Bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma